Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Wiksten

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Anticancer Research|May 1, 2001
A prognostic value of syndecan-1 in gastric cancerJ P Wiksten, J Lundin, S Nordling, et al.
Oncology|July 16, 2005
Epithelial syndecan-1 expression is associated with stage and grade in colorectal cancerM Lundin, S Nordling, J Lundin, et al.
Journal of Clinical Pathology|May 30, 2006
MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancerJ Mrena, J-P Wiksten, S Nordling, et al.
Histopathology|April 7, 2005
High tissue expression of tumour-associated trypsin inhibitor (TATI) associates with a more favourable prognosis in gastric cancerJ-P Wiksten, J Lundin, S Nordling, et al.
World Journal of Surgery|February 6, 1999
Distal pulse palpation: is it reliable?M Lundin, J P Wiksten, T Peräkylä, et al.
International Journal of Cancer|March 10, 2001
Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancerJ P Wiksten, J Lundin, S Nordling, et al.
Journal of Clinical Pathology|August 29, 2006
Decreased xanthine oxidoreductase is a predictor of poor prognosis in early-stage gastric cancerN Linder, C Haglund, M Lundin, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Anticancer Research|May 1, 2001
A prognostic value of syndecan-1 in gastric cancerJ P Wiksten, J Lundin, S Nordling, et al.
Oncology|July 16, 2005
Epithelial syndecan-1 expression is associated with stage and grade in colorectal cancerM Lundin, S Nordling, J Lundin, et al.
Journal of Clinical Pathology|May 30, 2006
MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancerJ Mrena, J-P Wiksten, S Nordling, et al.
Histopathology|April 7, 2005
High tissue expression of tumour-associated trypsin inhibitor (TATI) associates with a more favourable prognosis in gastric cancerJ-P Wiksten, J Lundin, S Nordling, et al.
World Journal of Surgery|February 6, 1999
Distal pulse palpation: is it reliable?M Lundin, J P Wiksten, T Peräkylä, et al.
International Journal of Cancer|March 10, 2001
Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancerJ P Wiksten, J Lundin, S Nordling, et al.
Journal of Clinical Pathology|August 29, 2006
Decreased xanthine oxidoreductase is a predictor of poor prognosis in early-stage gastric cancerN Linder, C Haglund, M Lundin, et al.
Pageof 1